Doctors won deadly meningitis

Many thousands of children's lives can be saved with the help of a new vaccine against meningitis, which should appear by the end of this year. It will work with meningitis type B - the most common in the world, against which currently there is no protection.

Clinical trials of a new drug, called 4CMenB, showed "amazing" results caused by "sustainable" immune response of thousands of newborns across Europe. Treatment of meningitis   using new vaccine protects 80% of the different variations of the disease. Meningitis UK Charity Association stated that the new   the vaccine against meningitis   It has the potential to save many thousands of lives in the country.

Meningitis type B can kill a child only four hours, it's most deadly variant of the disease. In a year in the UK alone is fixed to 1 200 new cases, while 10% of the patients die. But those who survive after treatment of meningitis , The disease often leaves the horrific consequences in the form of amputated limbs, blindness, deafness and brain damage.

Unfortunately, physicians currently can not provide any type of vaccine against meningitis B, although in practice a significant amount of long been used   the vaccine against meningitis   Type C, Hib-meningitis and pneumococcal meningitis. Developed by the pharmaceutical company Novartis a new vaccine has been tested on 1800 children, demonstrating its effectiveness as in "solo" use or in combination with other vaccines from different types of disease. Another phase of the study on 1500 infants has shown that the vaccine provides prophylactic protection, and the third stage has proved its effectiveness in adolescents.

Industry News

Go back to the main page